Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern: = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Berlin
2021
|
| Schlagworte: | |
| Beschreibung: | VI, 128 Blätter Illustrationen, Diagramme |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047472567 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 210917s2021 a||| m||| 00||| ger d | ||
| 035 | |a (OCoLC)1269387423 | ||
| 035 | |a (DE-599)BVBBV047472567 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-578 | ||
| 084 | |a QZ 266 |2 nlm | ||
| 084 | |a 610 |2 FUB | ||
| 100 | 1 | |a Schiele, Philipp |e Verfasser |0 (DE-588)1239087373 |4 aut | |
| 245 | 1 | 0 | |a Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern |b = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |c vorgelegt von Phillip Schiele |
| 246 | 1 | 1 | |a The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| 264 | 1 | |a Berlin |c 2021 | |
| 300 | |a VI, 128 Blätter |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Charité - Universitätsmedizin Berlin |d 2021 | ||
| 650 | 4 | |a glycoengineering | |
| 650 | 4 | |a EGFR | |
| 650 | 4 | |a CD40 | |
| 650 | 4 | |a PD-L1 | |
| 650 | 4 | |a checkpoint | |
| 650 | 4 | |a monoclonal antibodies | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |w (DE-604)BV047472562 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032874205 | ||
Datensatz im Suchindex
| _version_ | 1804182785314783232 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Schiele, Philipp |
| author_GND | (DE-588)1239087373 |
| author_facet | Schiele, Philipp |
| author_role | aut |
| author_sort | Schiele, Philipp |
| author_variant | p s ps |
| building | Verbundindex |
| bvnumber | BV047472567 |
| ctrlnum | (OCoLC)1269387423 (DE-599)BVBBV047472567 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01443nam a2200385 c 4500</leader><controlfield tag="001">BV047472567</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210917s2021 a||| m||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1269387423</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047472567</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QZ 266</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">FUB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schiele, Philipp</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1239087373</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern</subfield><subfield code="b">= The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies</subfield><subfield code="c">vorgelegt von Phillip Schiele</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 128 Blätter</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Charité - Universitätsmedizin Berlin</subfield><subfield code="d">2021</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">glycoengineering</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">EGFR</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">CD40</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PD-L1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">checkpoint</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">monoclonal antibodies</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="w">(DE-604)BV047472562</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032874205</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV047472567 |
| illustrated | Illustrated |
| index_date | 2024-07-03T18:09:53Z |
| indexdate | 2024-07-10T09:13:04Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032874205 |
| oclc_num | 1269387423 |
| open_access_boolean | |
| owner | DE-578 |
| owner_facet | DE-578 |
| physical | VI, 128 Blätter Illustrationen, Diagramme |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| record_format | marc |
| spelling | Schiele, Philipp Verfasser (DE-588)1239087373 aut Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies vorgelegt von Phillip Schiele The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies Berlin 2021 VI, 128 Blätter Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Dissertation Charité - Universitätsmedizin Berlin 2021 glycoengineering EGFR CD40 PD-L1 checkpoint monoclonal antibodies (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Online-Ausgabe (DE-604)BV047472562 |
| spellingShingle | Schiele, Philipp Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies glycoengineering EGFR CD40 PD-L1 checkpoint monoclonal antibodies |
| subject_GND | (DE-588)4113937-9 |
| title | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| title_alt | The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| title_auth | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| title_exact_search | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| title_exact_search_txtP | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| title_full | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies vorgelegt von Phillip Schiele |
| title_fullStr | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies vorgelegt von Phillip Schiele |
| title_full_unstemmed | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies vorgelegt von Phillip Schiele |
| title_short | Das Potenzial der Glyko-Optimierung bei kombinatorischen Krebs-Immuntherapien mit monoklonalen Antikörpern |
| title_sort | das potenzial der glyko optimierung bei kombinatorischen krebs immuntherapien mit monoklonalen antikorpern the potential of glyco optimization for combinatory anti cancer immunotherapies with monoclonal antibodies |
| title_sub | = The potential of glyco-optimization for combinatory anti-cancer immunotherapies with monoclonal antibodies |
| topic | glycoengineering EGFR CD40 PD-L1 checkpoint monoclonal antibodies |
| topic_facet | glycoengineering EGFR CD40 PD-L1 checkpoint monoclonal antibodies Hochschulschrift |
| work_keys_str_mv | AT schielephilipp daspotenzialderglykooptimierungbeikombinatorischenkrebsimmuntherapienmitmonoklonalenantikorpernthepotentialofglycooptimizationforcombinatoryanticancerimmunotherapieswithmonoclonalantibodies AT schielephilipp thepotentialofglycooptimizationforcombinatoryanticancerimmunotherapieswithmonoclonalantibodies |